Nueclear Web Banner
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
ORIGINAL ARTICLE
Ahead of Print

Evaluation of the use of nab-paclitaxel and gemcitabine in clinical practice


 Hospital Pharmacy Service, Estructura Organizativa de Gestión Integrada de Vigo - Hospital, Álvaro Cunqueiro, Vigo, Pontevedra, Spain

Correspondence Address:
Cristina Casanova-Martínez,
Camiño dos Cañotais 44, 36212 Vigo, Pontevedra
Spain
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Context: Pancreatic cancer in a common tumor in our country for which there are various treatment alternatives. Objective: Evaluate the effectiveness and safety of nab-paclitaxel and gemcitabine in everyday clinical practice. Settings and Design: Observational, retrospective study at a tertiary university hospital. Subjects and Methods: We included patients diagnosed of metastatic or locally advanced pancreatic cancer that were being treated with nab-paclitaxel and gemcitabine. We recorded response, progression-free survival (PFS), and overall survival (OS) rates together with toxicities. Statistical Analysis Used: We used SPSS program for Windows. We conducted descriptive statistics using averages, medians, standard deviations or ranges, and percentages. Results: We included 15 patients. At 3 months, there were no complete responses; 20% showed partial responses, and in 60% of patients, the disease stabilized. The median PFS was 8.9 months and the OS was 9.6. The most important adverse reactions were neutropenia, fatigue, and nausea/vomiting. Conclusions: The treatment regimen leads to increased survival in these patients with an acceptable toxicity profile.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Casanova-Martínez C
    -  Romero-Ventosa EY
    -  González-Costas S
    -  Arroyo-Conde C
    -  Piñeiro-Corrales G
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed364    
    PDF Downloaded20    

Recommend this journal